Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo

The transient receptor potential ankyrin 1 (TRPA1) channel has been extensively studied as a potential therapeutic target for the treatment of different pain types, with better efficacy and safety profiles compared to current therapies. Because TRPA1 is implicated in different pathophysiological processes, selective antagonists of this channel could provide therapeutic benefits beyond pain relief. In this study, we report the design and synthesis of a novel series of carboxamide derivatives incorporating an isoxazole moiety, which were evaluated for their ability to inhibit TRPA1-mediated signalling. Among these, we identified the TRPA1 antagonists 12 and 13 displaying nanomolar potency in vitro and significant analgesic effects against the TRPA1 agonist, allyl isothiocyanate and in the formalin test in mice. Docking analyses were also conducted to explore the binding modes of the most representative compounds with the proposed pharmacological target.

Authors

Institutions

Publication Details

Journal
European Journal of Medicinal Chemistry
Published
2025-05-09
DOI
https://doi.org/10.1016/j.ejmech.2025.117732
Citations
1
Primary Topic
Ion Channels and Receptors
Type
article
Field-Weighted Citation Impact
1.46

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo

Pierangelo Geppetti, Salvatore Pacifico, Chiara Sturaro, Matilde Marini et al.
1 citations
European Journal of Medicinal Chemistry
Ion Channels and Receptors
1.46
article

Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo

Pierangelo Geppetti, Salvatore Pacifico, Chiara Sturaro, Matilde Marini, M. Tesi, Chiara Ruzza, Delia Preti, Lorenzo Landini, Lorenzo Tagliazucchi, Elisa Bellantoni, Valentina Erminia Albanese, Remo Guerrini, Romina Nassini, Francesco De Logu, Sandro Cosconati, Michele Roggia, Lorenzo Gnudi, Valentina Puscio
article en
1 citations

Abstract

The transient receptor potential ankyrin 1 (TRPA1) channel has been extensively studied as a potential therapeutic target for the treatment of different pain types, with better efficacy and safety profiles compared to current therapies. Because TRPA1 is implicated in different pathophysiological processes, selective antagonists of this channel could provide therapeutic benefits beyond pain relief. In this study, we report the design and synthesis of a novel series of carboxamide derivatives incorporating an isoxazole moiety, which were evaluated for their ability to inhibit TRPA1-mediated signalling. Among these, we identified the TRPA1 antagonists 12 and 13 displaying nanomolar potency in vitro and significant analgesic effects against the TRPA1 agonist, allyl isothiocyanate and in the formalin test in mice. Docking analyses were also conducted to explore the binding modes of the most representative compounds with the proposed pharmacological target.

European Journal of Medicinal ChemistryVol. 294
University of Modena and Reggio Emilia (IT), University of Ferrara (IT), University of Campania "Luigi Vanvitelli" (IT), University of Florence (IT)
European Commission, Fondazione Telethon, Associazione Italiana per la Ricerca sul Cancro, Università degli Studi di Ferrara
Openalex Percentile: Top 22%
Ion Channels and Receptors
1.46
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.